| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP3-26333-50ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| IHC-Prediluted | NBP2-44713 | |||
| Azide and BSA Free | NBP2-34518-0.1mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| IHC-Prediluted | NBP2-44736 | |||
| Azide and BSA Free | NBP2-34652-0.1mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-33104 | |||
| IHC-Prediluted | NBP2-44839 | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-47941-0.1mg | |||
| IHC-Prediluted | NBP2-48125 | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-47942-0.1mg | |||
| IHC-Prediluted | NBP2-48143 | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NB100-56121SS | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| IHC-Prediluted | NBP2-44927 | |||
| Azide and BSA Free | NBP2-34655-0.1mg | |||
![Western Blot: Syntenin 1 Antibody (19C1) [NBP3-26333] - Positive Western Blot detected in: HT29 whole cell lysate, U87 whole cell lysate, Hela whole cell lysate, A549 whole cell lysate, HEPG2 whole cell lysate. All lanes: Syntenin 1 Antibody at 1: 1000 Secondary: Goat polyclonal to rabbit IgG at 1/50000 dilution. Predicted band size: 32 kDa Observed band size: 32 kDa](http://images.novusbio.com/fullsize/nbp3-26333_rabbit-syntenin-1-mab-19c1-28220241147217.jpg)
![Immunocytochemistry/Immunofluorescence: Syntenin 1 Antibody (19C1) [NBP3-26333] - Staining of Hela with Syntenin 1 Antibody (19C1) at 1:30, counter-stained with DAPI. The cells were fixed in 4% formaldehyde and blocked in 10% normal Goat Serum. The cells were then incubated with the antibody overnight at 4C. The secondary antibody was Alexa Fluor 521-conjugated Goat Anti-Rabbit IgG (H+L).](http://images.novusbio.com/fullsize/nbp3-26333_rabbit-syntenin-1-mab-19c1-28220241249364.jpg)
![Flow Cytometry: Syntenin 1 Antibody (19C1) [NBP3-26333] - Overlay Peak curve showing HepG2 cells stained with Syntenin 1 Antibody (19C1) (red line) at 1:50. The cells were fixed in 4% formaldehyde and permeated by 0.2% Triton X-100. Then 10% normal goat serum to block non-specific protein-protein interactions followed by the antibody (1ug/1*10^6 cells) for 45min at 4C. The secondary antibody used was FITC-conjugated Goat Anti-rabbit IgG (H+L) at 1:200 dilution for 35min at 4C. Control antibody (green line) was rabbit IgG (1ug/1*10^6 cells) used under the same conditions. Acquisition of >10,000 events was performed.](http://images.novusbio.com/fullsize/nbp3-26333_rabbit-syntenin-1-mab-19c1-282202414312716.jpg)
![Western Blot: NCAM-1/CD56 Antibody (123A8 (same as 56C04)) [NBP2-34279] - Western blot analysis of human brain tissue lysate using NCAM-1/CD56 antibody (123A8 (same as 56C04)).](http://images.novusbio.com/fullsize/NCAM-1-CD56-Antibody-123A8-same-as-56C04-Western-Blot-NBP2-34279-img0006.jpg "Western Blot: NCAM-1/CD56 Antibody (123A8 (same as 56C04)) [NBP2-34279] - Western blot analysis of human brain tissue lysate using NCAM-1/CD56 antibody (123A8 (same as 56C04)).")
![Immunohistochemistry-Paraffin: NCAM-1/CD56 Antibody (123A8 (same as 56C04)) [NBP2-34279] - Formalin-fixed, paraffin-embedded human colon stained with NCAM-1/CD56 Antibody (123A8 (same as 56C04)).](http://images.novusbio.com/fullsize/NCAM-1-CD56-Antibody-123A8-same-as-56C04-Immunohistochemistry-Paraffin-NBP2-34279-img0008.jpg)
![Immunohistochemistry-Paraffin: NCAM-1/CD56 Antibody (123A8 (same as 56C04)) [NBP2-34279] - Formalin-fixed, paraffin-embedded human Pancreas stained with NCAM-1/CD56 Antibody (123A8 (same as 56C04))](http://images.novusbio.com/fullsize/NCAM-1-CD56-Antibody-123A8-same-as-56C04-Immunohistochemistry-Paraffin-NBP2-34279-img0004.jpg)
![Immunohistochemistry: NCAM-1/CD56 Antibody (123A8 (same as 56C04)) [NBP2-34279] - Image of human cutaneous squamous cell carcinoma tumor stained with Anti-NCAM-1/CD56 Azide/BSA Free Antibody [123A8] (in red). IMC image submitted by a verified customer review.](http://images.novusbio.com/fullsize/NCAM-1-CD56-Antibody-123A8-same-as-56C04-Immunohistochemistry-NBP2-34279-img0005.jpg)
![Immunohistochemistry-Paraffin: NCAM-1/CD56 Antibody (123A8 (same as 56C04)) [NBP2-34279] - Formalin-fixed, paraffin-embedded human thyroid stained with NCAM-1/CD56 Antibody (123A8 (same as 56C04)). HIER: Tris/EDTA, pH9.0, 45min. HRP-polymer, 30min. DAB, 5min.](http://images.novusbio.com/fullsize/NCAM-1-CD56-Antibody-123A8-same-as-56C04-Immunohistochemistry-Paraffin-NBP2-34279-img0007.jpg)
![Western Blot: CD79A Antibody (JCB117) [NBP2-32949] - Western Blot Analysis of Raji cell lysate using CD79A antibody (JCB117).](http://images.novusbio.com/fullsize/CD79A-Antibody-JCB117-Western-Blot-NBP2-32949-img0007.jpg "Western Blot: CD79A Antibody (JCB117) [NBP2-32949] - Western Blot Analysis of Raji cell lysate using CD79A antibody (JCB117).")
![Immunocytochemistry/Immunofluorescence: CD79A Antibody (JCB117) [NBP2-32949] - Immunofluorescent staining of paraformaldehyde-fixed Raji cells. CD79A Antibody (JCB117) followed by goat anti-Mouse IgG-CF488 (Green). The nuclear counterstain is Red Dot (Red)](http://images.novusbio.com/fullsize/CD79A-Antibody-JCB117-Immunocytochemistry-Immunofluorescence-NBP2-32949-img0003.jpg)
![Immunohistochemistry-Paraffin: CD79A Antibody (JCB117) [NBP2-32949] - Formalin-fixed, paraffin-embedded human Tonsil stained with CD79A Antibody (JCB117).](http://images.novusbio.com/fullsize/CD79A-Antibody-JCB117-Immunohistochemistry-Paraffin-NBP2-32949-img0004.jpg)
![Flow Cytometry: CD79A Antibody (JCB117) [NBP2-32949] - Flow Cytometric Analysis of Raji cells. CD79A Antibody (JCB117) followed by goat anti-Mouse IgG-CF488 (Blue); Isotype Control (Red).](http://images.novusbio.com/fullsize/CD79A-Antibody-JCB117-Flow-Cytometry-NBP2-32949-img0006.jpg)
![Western Blot: CD79A Antibody (JCB117) [NBP2-32949] - Western Blot Analysis of human Raji cell lysate using CD79A Antibody (JCB117).](http://images.novusbio.com/fullsize/CD79A-Antibody-JCB117-Western-Blot-NBP2-32949-img0005.jpg)
![Immunohistochemistry-Paraffin: CD45RO Antibody (UCHL-1) [NBP2-29631] - Staining of human tonsil](http://images.novusbio.com/fullsize/CD45RO-Antibody-UCHL-1-Immunohistochemistry-Paraffin-NBP2-29631-img0004.jpg "Immunohistochemistry-Paraffin: CD45RO Antibody (UCHL-1) [NBP2-29631] - Staining of human tonsil")
![<b>Orthogonal Strategies Validation. </b>Dual RNAscope ISH-IHC: CD45RO Antibody (UCHL-1) [NBP2-29631] - Formalin-fixed paraffin-embedded tissue sections of human tonsil were probed for CD45 mRNA (ACD RNAScope probe, catalog # 601991; Fast Red chromogen, ACD catalog # 322500) followed by immunohistochemistry using mouse monoclonal (Novus catalog # NBP2-29631) at 5ug/mL for 1 hour at room temperature and detection with anti-mouse IgG VisUCyte HRP Polymer Antibody (R&D Systems Catalog # VC001) and green HRP chromogen (ACD Catalog # 322500).](http://images.novusbio.com/fullsize/CD45RO-Antibody-UCHL-1-Dual-RNAscope-ISH-IHC-NBP2-29631-img0006.jpg)
![Immunocytochemistry/Immunofluorescence: CD45RO Antibody (UCHL-1) [NBP2-29631] - Immunofluorescence Analysis of human tonsil FFPE section stained with CD45RO antibody (UCHL-1)and goat anti-mouse HRP, detected using CF488A tyramide in Tyramide Amplification Buffer Plus.](http://images.novusbio.com/fullsize/CD45RO-Antibody-UCHL-1-Immunocytochemistry-Immunofluorescence-NBP2-29631-img0008.jpg)
![Flow Cytometry: CD45RO Antibody (UCHL-1) [NBP2-29631] - Flow Cytometric Analysis of PFA-fixed Jurkat cells using CD45RO Antibody (UCHL-1) followed by Goat anti- Mouse- IgG-CF488 (Blue); Isotype Control (Red).](http://images.novusbio.com/fullsize/CD45RO-Antibody-UCHL-1-Flow-Cytometry-NBP2-29631-img0007.jpg)
![Flow Cytometry: CD45RO Antibody (UCHL-1) [NBP2-29631] - CD45RO expression by lymphocyte gated population of PBMC: PBMC were stained either with purified CD45RO antibody (0.5 ug/10^6 cells) or isotype control following surface staining protocol. PE-conjugated goat anti-mouse IgG, secondary antibody used to identify the positive staining on PPI negative lymphocyte gated population.](http://images.novusbio.com/fullsize/CD45RO-Antibody-UCHL-1-Flow-Cytometry-NBP2-29631-img0002.jpg)
![Immunocytochemistry/Immunofluorescence: CD40 Ligand/TNFSF5 Antibody (LL48) [DDX0140P-100] - IF staining of hCD40L-transfected L cells with LL48 clone](http://images.novusbio.com/fullsize/CD40-Ligand-TNFSF5-Antibody-LL48-Immunocytochemistry-Immunofluorescence-DDX0140P-100-img0005.jpg "Immunocytochemistry/Immunofluorescence: CD40 Ligand/TNFSF5 Antibody (LL48) [DDX0140P-100] - IF staining of hCD40L-transfected L cells with LL48 clone")
![Flow Cytometry: CD40 Ligand/TNFSF5 Antibody (LL48) [DDX0140P-100] - FACS staining of hCD40L-transfected L cells with LL48 clone](http://images.novusbio.com/fullsize/CD40-Ligand-TNFSF5-Antibody-LL48-Flow-Cytometry-DDX0140P-100-img0002.jpg)
![Neutralization: CD40 Ligand/TNFSF5 Antibody (LL48) [DDX0140P-100] - Inhibition of IL12 production by CD40L-stimulated human monocyte-derived DCs by LL48 clone (Stax AM et al, 2008, J ImmunolMethods)](http://images.novusbio.com/fullsize/CD40-Ligand-TNFSF5-Antibody-LL48-Neutralization-DDX0140P-100-img0003.jpg)
![Western Blot: Cytokeratin 7 Antibody (K72.7) [NBP2-44816] - Western Blot Analysis of human HeLa cell lysate using Cytokeratin 7 Antibody (K72.7).](http://images.novusbio.com/fullsize/Cytokeratin-7-Antibody-K72-7-Western-Blot-NBP2-44816-img0006.jpg "Western Blot: Cytokeratin 7 Antibody (K72.7) [NBP2-44816] - Western Blot Analysis of human HeLa cell lysate using Cytokeratin 7 Antibody (K72.7).")
![Immunocytochemistry/Immunofluorescence: Cytokeratin 7 Antibody (K72.7) [NBP2-44816] - Immunofluorescence Analysis of MeOH-fixed HeLa cells labeling KRT7 with Cytokeratin 7 Antibody (K72.7) followed by Goat anti-Mouse IgG-CF488 (Green). The nuclear counterstain is Red Dot](http://images.novusbio.com/fullsize/Cytokeratin-7-Antibody-K72-7-Immunocytochemistry-Immunofluorescence-NBP2-44816-img0005.jpg)
![Immunohistochemistry-Paraffin: Cytokeratin 7 Antibody (K72.7) [NBP2-44816] - Ovarian Carcinoma stained with Cytokeratin 7 Monoclonal Antibody (K72.7)](http://images.novusbio.com/fullsize/Cytokeratin-7-Antibody-K72-7-Immunohistochemistry-Paraffin-NBP2-44816-img0003.jpg)
![Flow Cytometry: Cytokeratin 7 Antibody (K72.7) [NBP2-44816] - Flow Cytometric Analysis of PFA-fixed HeLa cells using Cytokeratin 7 Antibody (K72.7)followed by Goat anti-Mouse IgG-CF488 (blue); Isotype Control (red).](http://images.novusbio.com/fullsize/Cytokeratin-7-Antibody-K72-7-Flow-Cytometry-NBP2-44816-img0004.jpg)
![Immunohistochemistry-Paraffin: Cytokeratin 7 Antibody (K72.7) [NBP2-44816] - Human Lung SCC stained with Cytokeratin 7 Monoclonal Antibody (K72.7)](http://images.novusbio.com/fullsize/Cytokeratin-7-Antibody-K72-7-Immunohistochemistry-Paraffin-NBP2-44816-img0001.jpg)
![Western Blot: Cytokeratin 7 Antibody (KRT7/760 + KRT7/903) [NBP2-44818] - Western Blot Analysis of human HeLa cell lysate using Cytokeratin 7 Antibody (KRT7/760 + KRT7/903).](http://images.novusbio.com/fullsize/Cytokeratin-7-Antibody-KRT7-760-+-KRT7-903-Western-Blot-NBP2-44818-img0005.jpg "Western Blot: Cytokeratin 7 Antibody (KRT7/760 + KRT7/903) [NBP2-44818] - Western Blot Analysis of human HeLa cell lysate using Cytokeratin 7 Antibody (KRT7/760 + KRT7/903).")
![Immunocytochemistry/Immunofluorescence: Cytokeratin 7 Antibody (KRT7/760 + KRT7/903) [NBP2-44818] - Immunofluorescence Analysis of HeLa cells labeling Cytokeratin 7 with Cytokeratin 7 Antibody (KRT7/760 + KRT7/903) conjugated with CF488 (Green). The nuclear counterstain is Red Dot (red).](http://images.novusbio.com/fullsize/Cytokeratin-7-Antibody-KRT7-760-+-KRT7-903-Immunocytochemistry-Immunofluorescence-NBP2-44818-img0004.jpg)
![Immunohistochemistry-Paraffin: Cytokeratin 7 Antibody (KRT7/760 + KRT7/903) [NBP2-44818] - Human Ovarian Carcinoma stained with Cytokeratin 7 Monoclonal Antibody (KRT7/760 + KRT7/903)](http://images.novusbio.com/fullsize/Cytokeratin-7-Antibody-KRT7-760-+-KRT7-903-Immunohistochemistry-Paraffin-NBP2-44818-img0003.jpg)
![Immunohistochemistry-Paraffin: Cytokeratin 7 Antibody (KRT7/760 + KRT7/903) [NBP2-44818] - Human Endometrial Carcinoma stained with Cytokeratin 7 Monoclonal Antibody (KRT7/760 + KRT7/903)](http://images.novusbio.com/fullsize/Cytokeratin-7-Antibody-KRT7-760-+-KRT7-903-Immunohistochemistry-Paraffin-NBP2-44818-img0001.jpg)
![Immunohistochemistry-Paraffin: Cytokeratin 7 Antibody (KRT7/760 + KRT7/903) [NBP2-44818] - Human Lung Carcinoma stained with Cytokeratin 7 Monoclonal Antibody (KRT7/760 + KRT7/903)](http://images.novusbio.com/fullsize/Cytokeratin-7-Antibody-KRT7-760-+-KRT7-903-Immunohistochemistry-Paraffin-NBP2-44818-img0002.jpg)
![Western Blot: Caspase-9 Antibody [NB100-56121] - Analysis of Caspase-9 in human HeLa cell lysate at 1:1000.](http://images.novusbio.com/fullsize/Caspase-9-Antibody-Western-Blot-NB100-56121-img0005.jpg "Western Blot: Caspase-9 Antibody [NB100-56121] - Analysis of Caspase-9 in human HeLa cell lysate at 1:1000.")
![Immunohistochemistry-Paraffin: Caspase-9 Antibody - Unpurified [NB100-56121] - Caspase-9 Antibody [NB100-56121] - analysis of formalin fixed paraffin-embedded (FFPE) human colon cancer using Caspase-9 antibody at 1:500 on a Bond Rx autostainer (Leica Biosystems). The assay involved 20 minutes of heat induced antigen retrieval (HIER) using 10mM sodium citrate buffer (pH 6.0) and endogenous peroxidase quenching with peroxide block. The sections were incubated with primary antibody for 30 minutes and Bond Polymer Refine Detection (Leica Biosystems) with DAB was used for signal development followed by counterstaining with hematoxylin. Whole slide scanning and capturing of representative images was performed using Aperio AT2 (Leica Biosystems). Cytoplasmic staining of Caspase 9 was observed. Staining was performed by Histowiz.](http://images.novusbio.com/fullsize/Caspase-9-Antibody-Immunohistochemistry-Paraffin-NB100-56121-img0006.jpg)
![Immunohistochemistry-Paraffin: Cytokeratin 8/18 Antibody (K8.8 + DC10) [NBP2-34344] - Formalin-fixed, paraffin-embedded human Overian cancer stained with Cytokeratin 8/18 Monoclonal Antibody (K8.8 + DC10).](http://images.novusbio.com/fullsize/Cytokeratin-8-18-Antibody-K8-8-+-DC10-Immunohistochemistry-Paraffin-NBP2-34344-img0002.jpg "Immunohistochemistry-Paraffin: Cytokeratin 8/18 Antibody (K8.8 + DC10) [NBP2-34344] - Formalin-fixed, paraffin-embedded human Overian cancer stained with Cytokeratin 8/18 Monoclonal Antibody (K8.8 + DC10).")
![Flow Cytometry: Cytokeratin 8/18 Antibody (K8.8 + DC10) [NBP2-34344] - Flow Cytometry: Cytokeratin 8/18 Antibody (K8.8 + DC10) [DyLight 550] [NBP2-34655R] - An intracellular stain was performed on HeLa cells with Cytokeratin 8/18 Antibody (K8.8 + DC10) NBP2-34655R (blue) and a matched isotype control (orange). Cells were fixed with 4% PFA and then permeabilized with 0.1% saponin. Cells were incubated in an antibody dilution of 5 ug/mL for 30 minutes at room temperature. Both antibodies were conjugated to Dylight 550. Image using the DyLight 550 form of this antibody.](http://images.novusbio.com/fullsize/Cytokeratin-8-18-Antibody-K8-8-+-DC10-Flow-Cytometry-NBP2-34344-img0005.jpg)
![Immunohistochemistry-Paraffin: Cytokeratin 8/18 Antibody (K8.8 + DC10) [NBP2-34344] - Formalin-fixed paraffin-embedded human colon carcinoma stained with cytokeratin 8/18 Monoclonal Antibody (K8.8 +DC10)](http://images.novusbio.com/fullsize/Cytokeratin-8-18-Antibody-K8-8-+-DC10-Immunohistochemistry-Paraffin-NBP2-34344-img0001.jpg)
![Western Blot: VCIP135/VCPIP1 Antibody [NBP1-32663] - Wild-type (WT) and VCPIP1 knockout (KO) HeLa cell extracts (30 ug) were separated by 5% SDS-PAGE, and the membrane was blotted with VCPIP1 antibody diluted at 1:1000. HRP-conjugated anti-rabbit IgG antibody was used to detect the primary antibody.](http://images.novusbio.com/fullsize/VCIP135-VCPIP1-Antibody-Western-Blot-NBP1-32663-img0015.jpg "<b>Genetic Strategies Validation. </b>Western Blot: VCIP135/VCPIP1 Antibody [NBP1-32663] - Wild-type (WT) and VCPIP1 knockout (KO) HeLa cell extracts (30 ug) were separated by 5% SDS-PAGE, and the membrane was blotted with VCPIP1 antibody diluted at 1:1000. HRP-conjugated anti-rabbit IgG antibody was used to detect the primary antibody.")
![<b>Genetic Strategies Validation. </b>Immunocytochemistry/Immunofluorescence: VCIP135/VCPIP1 Antibody [NBP1-32663] - HeLa cells were fixed in -20C 100% MeOH for 5 min. Green: VCPIP1 protein stained by VCPIP1 antibody, C-term diluted at 1:500. Blue: Hoechst 33343 staining.](http://images.novusbio.com/fullsize/VCIP135-VCPIP1-Antibody-Immunocytochemistry-NBP1-32663-img0011.jpg)
![Immunohistochemistry-Paraffin: VCIP135/VCPIP1 Antibody [NBP1-32663] - Paraffin-embedded SW480 xenograft, using antibody at 1:100 dilution.](http://images.novusbio.com/fullsize/VCIP135-VCPIP1-Antibody-Immunohistochemistry-Paraffin-NBP1-32663-img0012.jpg)
![Western Blot: VCIP135/VCPIP1 Antibody [NBP1-32663] - A: Mouse brain.](http://images.novusbio.com/fullsize/VCIP135-VCPIP1-Antibody-Western-Blot-NBP1-32663-img0013.jpg)
![Western Blot: VCIP135/VCPIP1 Antibody [NBP1-32663] - A: H1299.](http://images.novusbio.com/fullsize/VCIP135-VCPIP1-Antibody-Western-Blot-NBP1-32663-img0014.jpg)
![Western Blot: EMP2 Recombinant Protein [H00002013-P01] - analysis of EMP2 using anti-EMP2 antibody (Cat.# NBP1-86847). The EMP2 recombinant protein was used as a positive control. Image from verified customer review.](http://images.novusbio.com/fullsize/EMP2-Recombinant-Protein-Western-Blot-H00002013-P01-img0001.jpg "Western Blot: EMP2 Recombinant Protein [H00002013-P01] - analysis of EMP2 using anti-EMP2 antibody (Cat.# NBP1-86847). The EMP2 recombinant protein was used as a positive control. Image from verified customer review.")
![ELISA: EMP2 Recombinant Protein [H00002013-P01] - EMP2 recombinant protein coated into ELISA plate; used as a positive control for EMP2 antibody (Cat# NBP1-86847). Image from verified customer review.](http://images.novusbio.com/fullsize/EMP2-Recombinant-Protein-ELISA-H00002013-P01-img0002.jpg)
![Western Blot: beta II Tubulin A Antibody (3B2) [H00007280-M04] - Analysis of TUBB2A expression in Jurkat (Cat # L017V1).](http://images.novusbio.com/fullsize/beta-II-Tubulin-A-Antibody-3B2-Western-Blot-H00007280-M04-img0005.jpg "Western Blot: beta II Tubulin A Antibody (3B2) [H00007280-M04] - Analysis of TUBB2A expression in Jurkat (Cat # L017V1).")
![Immunocytochemistry/Immunofluorescence: beta II Tubulin A Antibody (3B2) [H00007280-M04] - Analysis of monoclonal antibody to TUBB2A on HeLa cell. Antibody concentration 10 ug/ml](http://images.novusbio.com/fullsize/beta-II-Tubulin-A-Antibody-3B2-Immunocytochemistry-Immunofluorescence-H00007280-M04-img0001.jpg)
![Immunohistochemistry-Paraffin: beta II Tubulin A Antibody (3B2) [H00007280-M04] - Analysis of monoclonal antibody to TUBB2A on formalin-fixed paraffin-embedded human colon. Antibody concentration 1.5 ug/ml](http://images.novusbio.com/fullsize/beta-II-Tubulin-A-Antibody-3B2-Immunohistochemistry-Paraffin-H00007280-M04-img0002.jpg)
![Western Blot: beta II Tubulin A Antibody (3B2) [H00007280-M04] - Analysis of TUBB2A expression in PC-12 (Cat # L012V1).](http://images.novusbio.com/fullsize/beta-II-Tubulin-A-Antibody-3B2-Western-Blot-H00007280-M04-img0003.jpg)
![Western Blot: beta II Tubulin A Antibody (3B2) [H00007280-M04] - Analysis of TUBB2A expression in Raw 264.7 (Cat # L024V1).](http://images.novusbio.com/fullsize/beta-II-Tubulin-A-Antibody-3B2-Western-Blot-H00007280-M04-img0004.jpg)
![Western Blot: beta II Tubulin A Antibody (3B2) [H00007280-M04] - Analysis of TUBB2A expression in NIH/3T3 (Cat # L018V1).](http://images.novusbio.com/fullsize/beta-II-Tubulin-A-Antibody-3B2-Western-Blot-H00007280-M04-img0006.jpg)